Amgen Inc.
MX ˙ BMV ˙ NL0000888691
SecurityMX:AMGN / Amgen Inc.
InstitutionCardinal Capital Management, Inc.
Latest Disclosed Ownership850 shares
Latest Disclosed Value $ 299,073
Cardinal Capital Management, Inc. ownership in AMGN / Amgen Inc.

On April 7, 2026 - Cardinal Capital Management, Inc. filed a 13F-HR form disclosing ownership of 850 shares of Amgen Inc. (MX:AMGN) valued at $299,073 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 22, 2026 disclosing 850 shares of Amgen Inc.. This represents a change in shares of 0.00% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2026-04-07 2026-03-31 13F Amgen COM 031162100 850 0 0.00 299 -21.52 0.0081
2026-01-22 2025-12-31 13F Amgen COM 031162100 850 0 0.00 382 59.41 0.0086
2025-10-03 2025-09-30 13F Amgen COM 031162100 850 0 0.00 240 0.84 0.0069
2025-07-11 2025-06-30 13F Amgen COM 031162100 850 0 0.00 237 -10.23 0.0074
2025-04-14 2025-03-31 13F Amgen COM 031162100 850 0 0.00 265 19.46 0.0090
2025-01-17 2024-12-31 13F Amgen COM 031162100 850 0 0.00 222 -19.05 0.0075
2024-10-10 2024-09-30 13F Amgen COM 031162100 850 -50 -5.56 274 -2.85 0.0113
2024-07-09 2024-06-30 13F Amgen COM 031162100 900 -100 -10.00 281 -1.06 0.0108
2024-04-09 2024-03-31 13F Amgen COM 031162100 1,000 0 0.00 284 -1.39 0.0126
2024-02-23 2023-12-31 13F Amgen COM 031162100 1,000 -1,425 -58.76 288 -55.76 0.0136
2023-10-12 2023-09-30 13F Amgen COM 031162100 2,425 -50 -2.02 652 18.58 0.0339
2023-07-10 2023-06-30 13F Amgen COM 031162100 2,475 -125 -4.81 550 -12.58 0.0275
2023-04-06 2023-03-31 13F Amgen COM 031162100 2,600 200 8.33 629 -0.32 0.0341
2023-02-03 2022-12-31 13F Amgen COM 031162100 2,400 0 0.00 630 16.45 0.0356
2022-10-07 2022-09-30 13F Amgen COM 031162100 2,400 0 0.00 541 -7.36 0.0330
2022-07-13 2022-06-30 13F Amgen COM 031162100 2,400 -25 -1.03 584 -0.34 0.0323
2022-04-12 2022-03-31 13F Amgen COM 031162100 2,425 -75 -3.00 586 4.27 0.0285
2022-01-19 2021-12-31 13F Amgen COM 031162100 2,500 0 0.00 562 5.64 0.0262
2021-10-07 2021-09-30 13F Amgen COM 031162100 2,500 -800 -24.24 532 -33.83 0.0291
2021-07-09 2021-06-30 13F Amgen COM 031162100 3,300 0 0.00 804 -2.07 0.0435
2021-04-14 2021-03-31 13F Amgen COM 031162100 3,300 -300 -8.33 821 -0.85 0.0483
2021-01-15 2020-12-31 13F Amgen COM 031162100 3,600 -35 -0.96 828 -10.39 0.0503
2020-10-13 2020-09-30 13F Amgen COM 031162100 3,635 -79,871 -95.65 924 -95.31 0.0662
2020-07-08 2020-06-30 13F Amgen COM 031162100 83,506 -140 -0.17 19,696 16.15 1.6626
2020-04-08 2020-03-31 13F Amgen COM 031162100 83,646 -1,323 -1.56 16,958 -17.21 1.4104
2020-01-15 2019-12-31 13F Amgen COM 031162100 84,969 -2,525 -2.89 20,483 20.98 1.3807
2019-10-08 2019-09-30 13F Amgen COM 031162100 87,494 -136 -0.16 16,931 4.85 1.5761
2019-07-11 2019-06-30 13F Amgen COM 031162100 87,630 -572 -0.65 16,148 -3.63 1.6072
2019-04-04 2019-03-31 13F Amgen COM 031162100 88,202 88,202 16,757 1.6758
2019-01-14 2018-12-31 13F Amgen COM 031162100 0 -82,685 -100.00 0 -100.00
2018-10-05 2018-09-30 13F Amgen COM 031162100 82,685 -215 -0.26 17,140 12.00 1.6335
2018-07-05 2018-06-30 13F Amgen COM 031162100 82,900 15,035 22.15 15,303 32.26 1.4792
2018-04-06 2018-03-31 13F Amgen COM 031162100 67,865 7,325 12.10 11,570 9.90 1.0849
2018-01-18 2017-12-31 13F Amgen COM 031162100 60,540 56,490 1,394.81 10,528 1,294.44 0.8895
2017-10-06 2017-09-30 13F Amgen COM 031162100 4,050 0 0.00 755 8.17 0.0699
2017-07-10 2017-06-30 13F Amgen COM 031162100 4,050 700 20.90 698 26.91 0.0706
2017-04-06 2017-03-31 13F Amgen COM 031162100 3,350 3,350 550 0.0570
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.